Pomanda estimates the enterprise value of KENEX (ELECTRO-MEDICAL) LIMITED at £6.1m based on a Turnover of £6.3m and 0.97x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KENEX (ELECTRO-MEDICAL) LIMITED at £7.2m based on an EBITDA of £1.3m and a 5.52x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KENEX (ELECTRO-MEDICAL) LIMITED at £12.1m based on Net Assets of £6.1m and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Kenex (electro-medical) LimitedOverview
Kenex (electro-medical) Limited is a live company located in harlow, CM19 5QB with a Companies House number of 00982587. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in June 1970, it's largest shareholder is
mr kenneth charles hunt
with a 57.1% stake. Kenex (electro-medical) Limited is a mature,
mid sized company, Pomanda has estimated its turnover at
£6.3m with
low
growth in recent years.
Pomanda's financial health check has awarded Kenex (Electro-Medical) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
4 Strong
2 Regular
6 Weak
Size
annual sales of £6.3m, make it smaller than the average company (£17.4m)
£6.3m - Kenex (electro-medical) Limited
£17.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (6.2%)
2% - Kenex (electro-medical) Limited
6.2% - Industry AVG
Production
with a gross margin of 36.1%, this company has a comparable cost of product (36.1%)
36.1% - Kenex (electro-medical) Limited
36.1% - Industry AVG
Profitability
an operating margin of 20% make it more profitable than the average company (6%)
20% - Kenex (electro-medical) Limited
6% - Industry AVG
Employees
with 23 employees, this is below the industry average (90)
23 - Kenex (electro-medical) Limited
90 - Industry AVG
Pay Structure
on an average salary of £50.4k, the company has an equivalent pay structure (£50.4k)
£50.4k - Kenex (electro-medical) Limited
£50.4k - Industry AVG
Efficiency
resulting in sales per employee of £273.5k, this is more efficient (£173.5k)
£273.5k - Kenex (electro-medical) Limited
£173.5k - Industry AVG
Debtor Days
it gets paid by customers after 91 days, this is later than average (51 days)
91 days - Kenex (electro-medical) Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 14 days, this is quicker than average (36 days)
14 days - Kenex (electro-medical) Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 120 days, this is more than average (95 days)
120 days - Kenex (electro-medical) Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 235 weeks, this is more cash available to meet short term requirements (13 weeks)
235 weeks - Kenex (electro-medical) Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10.9%, this is a lower level of debt than the average (41.9%)
10.9% - Kenex (electro-medical) Limited
41.9% - Industry AVG
KENEX (ELECTRO-MEDICAL) LIMITED financials
EXPORT
Kenex (Electro-Medical) Limited's latest turnover from June 2024 is estimated at £6.3 million and the company has net assets of £6.1 million. According to their latest financial statements, Kenex (Electro-Medical) Limited has 23 employees and maintains cash reserves of £3.4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Turnover
6,291,117
6,897,758
5,903,262
5,896,790
3,843,422
4,503,749
4,087,309
3,323,673
3,565,757
5,085,805
4,340,393
3,524,764
2,932,482
2,451,206
2,677,674
Other Income Or Grants
Cost Of Sales
4,021,783
4,265,625
3,626,324
3,723,831
2,354,625
2,767,893
2,543,179
2,020,827
2,023,812
2,938,114
2,512,439
2,067,656
1,725,650
1,444,564
1,548,649
Gross Profit
2,269,333
2,632,133
2,276,938
2,172,959
1,488,797
1,735,855
1,544,129
1,302,846
1,541,945
2,147,691
1,827,954
1,457,108
1,206,833
1,006,642
1,129,025
Admin Expenses
1,013,554
1,428,962
1,590,246
1,470,413
989,959
1,828,996
1,309,984
1,186,336
1,705,684
2,168,323
1,281,196
557,082
892,652
493,205
58,139
Operating Profit
1,255,779
1,203,171
686,692
702,546
498,838
-93,141
234,145
116,510
-163,739
-20,632
546,758
900,026
314,181
513,437
1,070,886
Interest Payable
Interest Receivable
145,033
96,339
19,159
1,283
869
5,091
3,900
2,525
6,477
6,728
6,249
4,902
3,963
2,762
893
Pre-Tax Profit
1,400,812
1,299,509
705,851
703,828
499,707
-88,050
238,044
119,036
-157,262
-13,904
553,006
904,927
318,145
516,199
1,071,779
Tax
-350,203
-324,877
-134,112
-133,727
-94,944
-45,228
-22,617
-116,131
-208,133
-76,355
-134,212
-300,098
Profit After Tax
1,050,609
974,632
571,739
570,101
404,763
-88,050
192,816
96,419
-157,262
-13,904
436,875
696,794
241,790
381,987
771,681
Dividends Paid
Retained Profit
1,050,609
974,632
571,739
570,101
404,763
-88,050
192,816
96,419
-157,262
-13,904
436,875
696,794
241,790
381,987
771,681
Employee Costs
1,159,605
1,226,563
1,211,121
1,090,014
1,014,994
1,058,227
903,454
879,683
752,497
1,426,182
1,181,419
948,439
805,344
708,235
781,068
Number Of Employees
23
25
26
23
22
23
21
21
20
38
32
27
23
20
23
EBITDA*
1,296,056
1,245,859
727,642
740,602
540,044
-48,043
282,586
167,439
-148,930
-12,765
556,109
906,483
320,668
521,015
1,080,420
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Tangible Assets
377,642
415,764
437,279
413,611
451,667
492,357
530,436
564,523
150,875
27,297
32,660
23,407
28,288
32,154
39,732
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
377,642
415,764
437,279
413,611
451,667
492,357
530,436
564,523
150,875
27,297
32,660
23,407
28,288
32,154
39,732
Stock & work in progress
1,325,833
1,321,262
1,109,667
880,696
834,289
808,356
696,816
643,002
606,273
579,155
508,593
498,026
479,720
467,889
405,094
Trade Debtors
1,578,210
1,675,833
1,280,168
1,313,982
805,775
1,053,100
994,036
763,097
764,768
1,056,898
878,629
653,674
521,626
399,971
470,766
Group Debtors
Misc Debtors
151,029
158,537
182,333
209,381
118,044
167,740
175,375
130,912
154,952
Cash
3,368,196
2,156,888
1,696,658
1,368,735
1,196,576
542,133
815,499
744,372
1,275,961
1,314,736
1,376,576
1,122,856
837,821
747,563
357,260
misc current assets
86,211
78,342
79,199
86,650
77,771
74,574
72,655
67,139
65,221
258,629
250,000
total current assets
6,509,479
5,390,862
4,348,025
3,859,444
3,032,455
2,649,733
2,756,300
2,354,038
2,869,093
3,016,010
3,022,427
2,524,556
1,839,167
1,615,423
1,233,120
total assets
6,887,121
5,806,626
4,785,304
4,273,055
3,484,122
3,142,090
3,286,736
2,918,561
3,019,968
3,043,307
3,055,087
2,547,963
1,867,455
1,647,577
1,272,852
Bank overdraft
Bank loan
Trade Creditors
164,179
264,010
301,769
435,107
236,646
215,688
232,304
201,748
456,636
519,530
516,653
447,475
463,274
484,698
492,086
Group/Directors Accounts
1,715
3,828
168
248
251
1,027
95,453
176
1,022
499
107
899
other short term finances
hp & lease commitments
other current liabilities
577,622
446,218
367,543
294,420
272,388
353,263
300,525
247,443
177,800
total current liabilities
743,516
714,056
669,480
729,775
509,285
569,978
628,282
449,367
635,458
520,029
516,760
448,374
463,274
484,698
492,086
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
9,115
8,689
6,575
5,770
7,428
9,466
7,758
11,314
23,049
4,555
5,700
3,837
5,223
5,711
5,585
total long term liabilities
9,115
8,689
6,575
5,770
7,428
9,466
7,758
11,314
23,049
4,555
5,700
3,837
5,223
5,711
5,585
total liabilities
752,631
722,745
676,055
735,545
516,713
579,444
636,040
460,681
658,507
524,584
522,460
452,211
468,497
490,409
497,671
net assets
6,134,490
5,083,881
4,109,249
3,537,510
2,967,409
2,562,646
2,650,696
2,457,880
2,361,461
2,518,723
2,532,627
2,095,752
1,398,958
1,157,168
775,181
total shareholders funds
6,134,490
5,083,881
4,109,249
3,537,510
2,967,409
2,562,646
2,650,696
2,457,880
2,361,461
2,518,723
2,532,627
2,095,752
1,398,958
1,157,168
775,181
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Operating Activities
Operating Profit
1,255,779
1,203,171
686,692
702,546
498,838
-93,141
234,145
116,510
-163,739
-20,632
546,758
900,026
314,181
513,437
1,070,886
Depreciation
40,277
42,688
40,950
38,056
41,206
45,098
48,441
50,929
14,809
7,867
9,351
6,457
6,487
7,578
9,534
Amortisation
Tax
-350,203
-324,877
-134,112
-133,727
-94,944
-45,228
-22,617
-116,131
-208,133
-76,355
-134,212
-300,098
Stock
4,571
211,595
228,971
46,407
25,933
111,540
53,814
36,729
27,118
70,562
10,567
18,306
11,831
62,795
405,094
Debtors
-105,131
371,869
-60,862
599,544
-297,021
51,429
275,402
-25,711
-137,178
178,269
224,955
132,048
121,655
-70,795
470,766
Creditors
-99,831
-37,759
-133,338
198,461
20,958
-16,616
30,556
-254,888
-62,894
2,877
69,178
-15,799
-21,424
-7,388
492,086
Accruals and Deferred Income
131,404
78,675
73,123
22,032
-80,875
52,738
53,082
69,643
177,800
Deferred Taxes & Provisions
426
2,114
805
-1,658
-2,038
1,708
-3,556
-11,735
18,494
-1,145
1,863
-1,386
-488
126
5,585
Cash flow from operations
1,078,412
380,548
366,011
179,759
654,233
-173,182
-11,776
-63,176
94,530
-259,864
275,497
530,811
88,915
387,541
402,133
Investing Activities
capital expenditure
-2,155
-21,173
-64,618
-516
-7,019
-14,354
-464,577
-138,387
-2,504
-18,604
-1,576
-2,621
-49,266
Change in Investments
cash flow from investments
-2,155
-21,173
-64,618
-516
-7,019
-14,354
-464,577
-138,387
-2,504
-18,604
-1,576
-2,621
-49,266
Financing Activities
Bank loans
Group/Directors Accounts
-2,113
3,660
-80
-3
-776
-94,426
95,277
-846
523
392
-792
899
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
3,500
interest
145,033
96,339
19,159
1,283
869
5,091
3,900
2,525
6,477
6,728
6,249
4,902
3,963
2,762
893
cash flow from financing
142,920
99,999
19,079
1,280
93
-89,335
99,177
1,679
7,000
7,120
5,457
5,801
3,963
2,762
4,393
cash and cash equivalents
cash
1,211,308
460,230
327,923
172,159
654,443
-273,366
71,127
-531,589
-38,775
-61,840
253,720
285,035
90,258
390,303
357,260
overdraft
change in cash
1,211,308
460,230
327,923
172,159
654,443
-273,366
71,127
-531,589
-38,775
-61,840
253,720
285,035
90,258
390,303
357,260
kenex (electro-medical) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for kenex (electro-medical) limited. Get real-time insights into kenex (electro-medical) limited's credit score, group structure and payment trends.
Perform a competitor analysis for kenex (electro-medical) limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in CM19 area or any other competitors across 12 key performance metrics.
kenex (electro-medical) limited Ownership
KENEX (ELECTRO-MEDICAL) LIMITED group structure
Kenex (Electro-Medical) Limited has no subsidiary companies.
Ultimate parent company
KENEX (ELECTRO-MEDICAL) LIMITED
00982587
KENEX (ELECTRO-MEDICAL) LIMITED Shareholders
The largest shareholders in Kenex (Electro-Medical) Limited include Mr Kenneth Charles Hunt and Mrs Susan Kathleen Hunt.
mr kenneth charles hunt
57.14%
mrs susan kathleen hunt
28.57%
paul andrew hunt
14.29%
kenex (electro-medical) limited directors
Kenex (Electro-Medical) Limited currently has 3 directors.
The longest serving directors include
Mr Kenneth Hunt (May 1992) and
Mrs Susan Hunt (May 1992).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to kenex (electro-medical) limited. Currently there are 1 open charges and 1 have been satisfied in the past.
kenex (electro-medical) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KENEX (ELECTRO-MEDICAL) LIMITED. This can take several minutes, an email will notify you when this has completed.
kenex (electro-medical) limitedCompanies House Filings - See Documents
